Table 2.
Stimuli | Stability | Modification | Modification Enzyme | Experimental Methods | Reference | ||||
---|---|---|---|---|---|---|---|---|---|
Protein Level | Half-Life | Ubiquitination | Proteasome Inhibitor | ||||||
DUSP1 | Serum | ↓ | Phosphorylation↑ (human Ser296 †/Ser323 †); Ubiquitination↑ |
ERK; CUL1 | ✓ | ✓ | ✓ | LLnL; MG132 | [28,54] |
Estradiol | ↑ | Phosphorylation↑ (human Ser359 †/Ser364 †) | ERK | ✓ | ✓ | ✓ | LLnL; MG132; Lactacystin | [56] | |
LPS | ↑ | Phosphorylation↑ (human Ser359 †/Ser364 †) | ERK | ✓ | ✓ | ? | MG132; PS-341 | [57] | |
Pb2+ | ↓ | Ubiquitination↑ | ✓ | ✓ | ✓ | LLnL; MG132 | [27] | ||
Glutamate/ PKCδ | ↓ | Ubiquitination↑ | ✓ | ✓ | MG132; LLnL; Lactacystin | [31] | |||
Atrogin-1 upregulation | ↓ | Ubiquitination↑ | Atrogin-1 | ✓ | ✓ | ✓ | MG132 | [33] | |
USP49 upregulation | ↑ | Ubiquitination↓ | USP49 | ✓ | ✓ | MG132 | [34] | ||
KLF5 upregulation | ↑ | Phosphorylation↑ (human Ser359 †/Ser364 †) | ERK | ✓ | ✓ | MG132 | [58] | ||
LPS | ↑ | Phosphorylation↑ (human Ser359 †/Ser364 †) | ERK | ✓ | ✓ | [59] | |||
Insulin | ↑ | Phosphorylation↑ | ✓ | MG132; Lactacystin | [63] | ||||
Asbestos/ ROS | ↓ | Oxidation↑ | ✓ | MG132 | [82] | ||||
TNFα/ ROS | ↓ | Oxidation↑ | ✓ | MG132 | [79] | ||||
ROS | ↓ | S-glutathionylation↑ (human Cys258 †) | ✓ | MG132 | [81] | ||||
Glucocorticoid | ↑ | ✓ | MG132; LLnL | [60] | |||||
EGF plus Lactoferrin | ↓ | ✓ | MG132 | [32] | |||||
Angiotensin II/ PKA | ↓ | ✓ | Bortezomib | [35] | |||||
CaMKII inhibition | ↓ | ✓ | MG132 | [64] | |||||
Luteolin/ Superoxide | ↓ | ✓ | ✓ | MG132 | [80] | ||||
DUSP2 | ERK4 | ↑ | ✓ | ✓ | [65] | ||||
DUSP4 | LPS | ↑ | Phosphorylation↑ (human Ser386 †/Ser391 †) | ERK | ✓ | ✓ | ? | MG132; PS-341 | [57] |
ERK inhibitor | ↓ | Phosphorylation↓ (human Ser386 †/Ser391 †); Ubiquitination↑ |
ERK | ✓ | ✓ | ✓ | MG132 | [67] | |
Cd2+ / Oxidative stress | ↓ | Oxidation↑ | GSSG | ✓ | [83] | ||||
8-Bromo-cAMP | ↑ | ✓ | ✓ | MG132 | [38] | ||||
Senescence | ↑ | ✓ | ✓ | MG132 | [37] | ||||
DUSP5 | ERK2 binding | ↑ | Ubiquitination↓ | ✓ | ✓ | ✓ | MG132 | [39] | |
DUSP6 | Serum | ↓ | Phosphorylation↑ (human Ser159 †/Ser197 †) Ubiquitination↑ |
ERK | ✓ | ✓ | ✓ | LLnL; Lactacystin | [70,73] |
ROS | ↓ | Phosphorylation↑ (human Ser159 †/Ser197 †); Ubiquitination↑ |
✓ | ✓ | MG132 | [43] | |||
PDGF | ↓ | Phosphorylation↑ (human Ser174 †); Ubiquitination↑ | ✓ | ✓ | ✓ | MG132 | [74] | ||
P2X7 nucleotide, EGF | ↓ | Phosphorylation↑ (human Ser197 †) | ERK | ✓ | ✓ | MG132 | [71] | ||
Insulin | ↓ | Phosphorylation↑ (human Ser159 †/Ser197 †) | ERK | ✓ | ✓ | [72] | |||
Amino acid, insulin, IGF-1/ mTOR | ↓ | Phosphorylation↑ (human Ser159 †) | ✓ | ✓ | [73] | ||||
PKCδ downregulation | ↓ | ✓ | MG132 | [46] | |||||
TSH | ↑ | ✓ | ✓ | MG132 | [44] | ||||
Metformin/ AMP-activated protein kinase | ↓ | ✓ | MG132 | [45] | |||||
EGF plus Lactoferrin | ↓ | ✓ | MG132 | [32] | |||||
DUSP7 | Hypoxic stress/ HIFs | ↓ | Ubiquitination↑ | SPOP | ✓ | ✓ | MG132 | [47] | |
DUSP8 | Anisomycin | ↓ | Phosphorylation↑; Ubiquitination↑ | JNK | ✓ | ✓ | ? | Lactacystin | [52] |
DUSP9 | LincU upregulation | ↑ | Ubiquitination↓ | ✓ | ✓ | ✓ | MG132 | [53] | |
DUSP10 | Insulin | ↑ | Phosphorylation↑ (human Ser224 †/Ser230 †) | mTORC2 | ✓ | ✓ | [75] | ||
DUSP14 | TCR signaling | (Activity↑) | Methylation↑ (human Arg17 †/Arg38 †/Arg45); Ubiquitination↑ (human Lys103 †) | PRMT5; TRAF2 | ✓ | ✓ | [86,87] | ||
DUSP16 | ERK upregulation | ↑ | Phosphorylation↑ (human Ser446 †); Ubiquitination↓ | ERK | ✓ | ✓ | ✓ | MG132; MG115 | [77,78] |
† denotes the amino acid residue is conserved in both human and mouse proteins. LPS denotes lipopolysaccharides. TSH denotes thyroid-stimulating hormone. GSSG denotes glutathione disulfide.